[{"Assets_0_Q2_USD":733997000.0,"CIK":"1737287","CommonStockSharesConverted_0_Q2_shares":121631278.0,"CommonStockSharesOutstanding_0_Q2_shares":121631278.0,"Country":"United States","EarningsPerShareBasic_1_Q2_USD":-0.41,"EarningsPerShareBasic_2_Q2_USD":-0.74,"Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","Market Cap":"1134878416.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":-55148000.0,"NetIncomeLossConverted_1_Q2_USD":-41243000.0,"NetIncomeLossConverted_2_Q2_USD":-72829000.0,"OfficialName":"Allogene Therapeutics Inc. Common Stock","SP500":"nan","Sector":"Health Care","StockholdersEquity_0_Q2_USD":655635000.0,"Ticker":"ALLO","filed":"20190807","footnote":"nan","form":"10-Q","fp":"Q2","fy":"2019.0","name":"ALLOGENE THERAPEUTICS, INC.","period":"20190630","qtrs":"0","uom":"USD"}]